XML 72 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
11 Months Ended
Dec. 31, 2024
Stock-Based Compensation [Abstract]  
Schedule of Weighted-Average Assumptions Used in Calculating the Fair Value of the Awards

The following table summarizes the weighted-average assumptions used in calculating the fair value of the awards for the period from February 6, 2024 (inception) to December 31, 2024:

 

   Period from
February 6,
2024
(Inception) to
December 31,
2024
 
Expected term (in years)   6.1 
Expected volatility   100.21%
Risk-free interest rate   4.26%
Expected dividend yield    

The following table summarizes the weighted-average assumptions used in calculating the fair value of the warrants for the period from February 6, 2024 (inception) to December 31, 2024:

 

   Period from
February 6,
2024
(Inception) to
December 31,
2024
 
Expected term (in years)   6.1 
Expected volatility   99.02%
Risk-free interest rate   4.15%
Expected dividend yield    
Schedule of Stock Option Activity

The following table summarizes the stock option activities under the 2024 Plan and 2024 Stock Plan for the period of February 6, 2024 (inception) through December 31, 2024:

 

   Number of
Stock
Options
Outstanding
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(in Years)
   Aggregate
Intrinsic
Value
(in Thousands)
 
Balance as of February 6, 2024 (inception)      $       $ 
Granted   1,567,760   $11.39           
Exercised      $           
Forfeited      $           
Balance as of December 31, 2024   1,567,760   $11.39    9.4   $15,470 
Vested and expected to vest, December 31, 2024   1,567,760   $11.39    9.4   $15,470 
Exercisable, December 31, 2024      $       $ 
Schedule of RSA Activity

The following table summarizes the RSA activity for the period from February 6, 2024 (inception) through December 31, 2024:

 

   Number of
RSAs
   Weighted
Average
Grant Date
Fair Value
 
Unvested balance as of February 6, 2024 (inception)      $ 
Granted   2,207,553   $ 
Unvested balance as of December 31, 2024   2,207,553   $ 
Schedule of Employee Warrant Activity

The following table summarizes the warrant activity for the period from February 6, 2024 (inception) through December 31, 2024: 

 

   Number of
Employee
Warrants
Outstanding
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(in Years)
   Aggregate
Intrinsic
Value
(in Thousands)
 
Balance as of February 6, 2024 (inception)      $       $ 
Granted   3,054,358   $7.80           
Exercised      $           
Forfeited      $           
Balance as of December 31, 2024   3,054,358   $7.80    9.5   $35,400 
Vested and expected to vest, December 31, 2024   3,054,358   $7.80    9.5   $35,400 
Exercisable, December 31, 2024      $       $ 
Schedule of Company’s Stock-Based Compensation Expense

The following table summarizes the classification of the Company’s stock-based compensation expense in the consolidated statement of operations and comprehensive loss (in thousands):

 

   Period from
February 6,
2024
(Inception) to
December 31,
2024
 
Research and development  $11,992 
General and administrative   2,927 
Total  $14,919 
Schedule of Award Types of Company’s Stock-Based Compensation Expense

The following table summarizes the award types of the Company’s stock-based compensation expense in the consolidated statement of operations and comprehensive loss (in thousands):

 

   Period from
February 6,
2024
(Inception) to
December 31,
2024
 
Paruka Warrant Obligation  $10,357 
Employee warrants   2,899 
Stock options   1,626 
Employee stock purchase plan   37 
Total  $14,919